[1]FDA. Providing Regulatory Submission in Electronic Format - General Considerations[S/OL]. [1999-01-01].https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm072390.pdf
[2]FDA. Providing Regulatory Submissions In Electronic Format - Standardized Study Data[S/OL]. [1999-12-01].https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm292334.pdf
[3]吴崇胜, 包文俊, 王军, 等. CDISC 标准介绍及在中国的应用[J].药学学报,2015,50(11):1428-1433.
[4]CDISC. CDISC Vision and Mission[EB/OL].[2015-01-28]. http://www.cdisc.org/CDISC-Vision-and-Mission.
[5]陆芳, 李庆娜, 赵阳, 等.中药新药临床研究数据管理应用CDISC 标准的初步探讨[J].中国中医药信息杂志,2016,23(1):9-14
[6]CDISC. Analysis Data Model (ADaM), Implementation Guide (IG) and appendices[EB/OL]. [2016-02-12].http://www.cdisc.org/adam.
[7]Pinnacle 21 Community. Pinnacle 21 LLC, Pinnacle 21 Community Toolset[EB/OL].2017. http://www.pi nnacle21.net/.
[8]Wendi L. Wright. "How to Create an XML Map with the XML Mapper"[R/OL].NESUG 2010.http://www.lexjansen.com/nesug/nesug10/ff/ff14.pdf
[9]陆芳,高蕊,唐旭东,等.临床研究中的数据管理标准CDISC及其应用前景[J].中国新药杂志,2011,20(24):2400-2404.
[10]王骏,韩景静,黄钦.从药品技术审评谈临床试验的数据标准化[J].中国新药杂志,2014,23(19):2228-2230,2279. |